BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17598012)

  • 1. Investigation of Thr715Pro P-selectin gene polymorphism and soluble P-selectin levels in type 2 diabetes mellitus.
    Nagy B; Csongrádi E; Bhattoa HP; Balogh I; Blaskó G; Paragh G; Kappelmayer J; Káplár M
    Thromb Haemost; 2007 Jul; 98(1):186-91. PubMed ID: 17598012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of P-selectin are determined by platelet turn-over and the P-selectin Thr715Pro polymorphism.
    Panzer S; Rosales S; Gisslinger H; Jungbauer L; Kaider A; Knöbl P; Sillaber C; Pabinger I
    Thromb Res; 2008; 121(4):573-9. PubMed ID: 17698171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-selectin gene genotypes or haplotypes and cardiovascular complications in type 2 diabetes mellitus.
    Zalewski G; Ciccarone E; Di Castelnuovo A; Zito F; Capani F; de Gaetano G; Donati MB; Iacoviello L;
    Nutr Metab Cardiovasc Dis; 2006 Sep; 16(6):418-25. PubMed ID: 16935700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P-selectin gene haplotypes modulate soluble P-selectin concentrations and contribute to the risk of venous thromboembolism.
    Ay C; Jungbauer LV; Kaider A; Koder S; Panzer S; Pabinger I; Mannhalter C
    Thromb Haemost; 2008 May; 99(5):899-904. PubMed ID: 18449419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of toll-like receptor-4 gene polymorphisms on soluble P-selectin and von Willebrand factor levels in hypercholesterolemic patients.
    Di Nisio M; Di Febbo C; Moretta V; Guglielmi MD; Stuppia L; Cuccurullo F; Porreca E
    Thromb Haemost; 2007 Sep; 98(3):642-6. PubMed ID: 17849054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the Thr789Ala variant of the von Willebrand factor levels, on ristocetin co-factor and collagen binding capacity and its association with coronary heart disease in patients with diabetes mellitus type 2.
    Klemm T; Mehnert AK; Siegemund A; Wiesner TD; Gelbrich G; Blüher M; Paschke R
    Exp Clin Endocrinol Diabetes; 2005 Dec; 113(10):568-72. PubMed ID: 16320153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour necrosis factor receptors (TNFRs) in Type 2 diabetes. Analysis of soluble plasma fractions and genetic variations of TNFR2 gene in a case-control study.
    Vendrell J; Broch M; Fernandez-Real JM; Gutiérrez C; Simón I; Megia A; Gallart L; Ricart W; Richart C
    Diabet Med; 2005 Apr; 22(4):387-92. PubMed ID: 15787661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Trp64Arg beta3-adrenergic receptor amino-acid variant is not associated with overweight and type 2 diabetes mellitus in Polish population.
    Kasznicki J; Blasiak J; Majsterek I; Przybyłowska K; Drzewoski J
    Exp Clin Endocrinol Diabetes; 2005 Dec; 113(10):593-7. PubMed ID: 16320158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk for thromboembolic disease in lupus anticoagulant patients due to pathways involving P-selectin and CD154.
    Bugert P; Pabinger I; Stamer K; Vormittag R; Skeate RC; Wahi MM; Panzer S
    Thromb Haemost; 2007 Apr; 97(4):573-80. PubMed ID: 17393020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the PPARalpha L162V polymorphism, plasma lipoprotein levels, and atherosclerotic disease in patients with diabetes mellitus type 2 and in nondiabetic controls.
    Gouni-Berthold I; Giannakidou E; Müller-Wieland D; Faust M; Kotzka J; Berthold HK; Krone W
    Am Heart J; 2004 Jun; 147(6):1117-24. PubMed ID: 15199365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The plasma levels of soluble P-selectin in subjects with prediabetes.
    Dogru T; Tasci I; Sonmez A; Genc H; Gok M; Yilmaz MI; Ural AU; Olgun A; Kilic S; Bozoglu E; Erdem G; Erbil K
    Int J Clin Pract; 2006 Sep; 60(9):1048-52. PubMed ID: 16939545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of angiotensin-converting enzyme gene polymorphism with nephropathy associated with Type 2 diabetes mellitus in Asian Indians.
    Movva S; Alluri RV; Komandur S; Vattam K; Eppa K; Mukkavali KK; Mubigonda S; Saharia S; Shastry JC; Hasan Q
    J Diabetes Complications; 2007; 21(4):237-41. PubMed ID: 17616353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between the Thr715Pro P-selectin gene polymorphism and soluble P-selectin levels in a multiethnic population in South London.
    Miller MA; Kerry SM; Dong Y; Strazzullo P; Cappuccio FP
    Thromb Haemost; 2004 Nov; 92(5):1060-5. PubMed ID: 15543334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of
    Alzahrani FM; Alhassan JA; Alshehri AM; Farooqi FA; Aldossary MA; Abdelghany MK; Ibrahim H; El-Masry OS
    Saudi J Biol Sci; 2023 Mar; 30(3):103579. PubMed ID: 36844639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ser128Arg E-selectin and Thr715Pro P-selectin polymorphisms and severe preeclampsia.
    Derzbach L; Balogh A; Bokodi G; Vásárhelyi B; Rigó J
    J Reprod Med; 2007 Sep; 52(9):815-8. PubMed ID: 17939599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene polymorphisms and antigen levels of matrix metalloproteinase-1 in type 2 diabetes mellitus coexisting with coronary heart disease.
    Drzewoski J; Sliwińska A; Przybyłowska K; Sliwiński T; Kasznicki J; Zurawska-Klis M; Kosmalski M; Majsterek I
    Kardiol Pol; 2008 Oct; 66(10):1042-8; discussion 1049. PubMed ID: 19006025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E-selectin S128R polymorphism leads to severe asthma.
    Nadi E; Hajilooi M; Zeraati F; Ansari M; Tavana S; Hashemi SH; Rafiei A
    Iran J Allergy Asthma Immunol; 2007 Jun; 6(2):49-57. PubMed ID: 17563404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P-selectin Thr715Pro polymorphism predicts P-selectin levels but not risk of incident coronary heart disease or ischemic stroke in a cohort of 14595 participants: the Atherosclerosis Risk in Communities Study.
    Volcik KA; Ballantyne CM; Coresh J; Folsom AR; Wu KK; Boerwinkle E
    Atherosclerosis; 2006 May; 186(1):74-9. PubMed ID: 16125711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
    Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
    Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of TCF7L2 polymorphism with diabetes mellitus, metabolic syndrome, and markers of beta cell function and insulin resistance in a population-based sample of Emirati subjects.
    Saadi H; Nagelkerke N; Carruthers SG; Benedict S; Abdulkhalek S; Reed R; Lukic M; Nicholls MG
    Diabetes Res Clin Pract; 2008 Jun; 80(3):392-8. PubMed ID: 18282631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.